Company: CERO
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001213900-25-073849
Chunk: 34

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-11
Form: S-3
Chunk 34
---
orporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on June 30, 2025). |
|:------|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 23.1* |     | Consent of Wolf & Company, P.C., independent registered public accounting firm.                                                                                                                                                              |
| 23.2* |     | Consent of Goodwin Procter LLP (included as part of Exhibit 5.1).                                                                                                                                                                            |
| 24.1* |     | Power of Attorney (included on signature page to this registration statement).                                                                                                                                                               |
| 107*  |     | Filing Fee Table.                                                                                                                                                                                                                            |

| * | Filed herewith. |

| † | Certain portions of this document that constitute confidential information 
 have been redacted pursuant to Item 601(b)(10) of Regulation S-K.          |

Item 17.
Undertakings

| (a) | The undersigned registrant hereby undertakes: |

(1) To file, during
any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) to
include any prospectus required by Section 10(a)(3) of the Securities Act;

<div align='center'>II-4</div>

(ii) to
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement; and

(iii) to
include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement;

provided, however, that: Paragraphs (a)(1)(i), (a)(